Publications by authors named "Xavier Andreu"

Claim this Profile
O
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
Bálint Cserni, Darren Kilmartin, Mark O'Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoid cystic carcinoma and basaloid carcinoma of the breast: A clinicopathological study.
Vicente Marco, Felip Garcia, Isabel T Rubio, Teresa Soler, Laura Ferrazza, Xavier Andreu

Rev Esp Patol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
Darren Kilmartin, Mark O'Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
Mark O'Loughlin, Xavier Andreu, Simonetta Bianchi, Ewa Chemielik, Alicia Cordoba

Breast Cancer Res Treat· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Gábor Cserni, Tamás Zombori, Xavier Andreu, Simonetta Bianchi, Peter Regitnig

Pathol Oncol Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis.
Antonio Martínez-Aranda, Vanessa Hernández, Ferran Moreno, Núria Baixeras, Daniel Cuadras, Xavier Andreu

Front Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
Antonio Martínez-Aranda, Vanessa Hernández, Emre Guney, Laia Muixí, Ruben Foj, Xavier Andreu

Oncotarget· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Nephrotic proteinuria in hypertensive nephrosclerosis: clinical and evolution characteristics].
Nàdia Martín Alemany, Jaume Almirall Daly, Ruth Orellana Fernández, Xavier Andreu

Med Clin (Barc)· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 blockade in metastatic collecting duct carcinoma (CDC) of the kidney: a case report.
Miguel H Bronchud, Sergi Castillo, Santiago Escriva de Romaní, Santiago Mourelo, Alejandra Fernández, Xavier Andreu

Onkologie· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The great mimicker: fat necrosis of the breast--magnetic resonance mammography approach.
Sergi Ganau, Lidia Tortajada, Fernanda Escribano, Xavier Andreu, Melcior Sentís

Curr Probl Diagn Radiol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
Joan Albanell, Xavier Andreu, María José Calasanz, Angel Concha, José María Corominas

Clin Transl Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interval breast cancers in a community screening programme: frequency, radiological classification and prognostic factors.
Marisa Baré, Melcior Sentís, Jaume Galceran, Alberto Ameijide, Xavier Andreu

Eur J Cancer Prev· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.
Luis A Fernández-Morales, Miquel A Seguí, Xavier Andreu, Elsa Dalmau, Amparo Sáez

Clin Breast Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between the method of detection and prognostic factors for breast cancer in a community with a screening programme.
Marisa Baré, Xavier Bonfill, Xavier Andreu,

J Med Screen· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis